Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
The study of sleep peptides covers a group of endogenous signaling molecules that laboratory researchers have examined in relation to sleep architecture and circadian timing. The most frequently referenced member of this group is Delta Sleep-Inducing Peptide (DSIP), a small nonapeptide first characterized in rabbit studies during the 1970s. DSIP takes its name from an observation reported in early animal experiments: its presence coincided with increased delta-wave (slow-wave) activity on the electroencephalogram (EEG). In contemporary preclinical work, DSIP is treated as a neuromodulatory research peptide rather than as a defined therapeutic agent.
Beyond DSIP, the broader field of circadian biology examines several peptides that participate in the timing signals generated by the brain’s master clock, the suprachiasmatic nucleus (SCN). These include vasoactive intestinal peptide, orexin (also called hypocretin), and growth hormone-releasing hormone, each of which has been investigated in animal models for a role in the sleep-wake cycle. This overview summarizes what these compounds are, the pathways and targets they are studied against, and the laboratory considerations relevant to handling them. All information here is provided for scientific and educational purposes only.
What Delta Sleep-Inducing Peptide Is
Discovery and naming
DSIP was isolated by Monnier and Schoenenberger from the cerebral venous blood of rabbits during electrically induced sleep. Their work suggested that a small peptide fraction was associated with the appearance of delta EEG frequencies, which led to the descriptive name delta sleep-inducing peptide. It is important to read this name carefully: it reflects an observed correlation in an animal preparation and does not establish a settled mechanism, and it does not describe a human sleep effect. Decades of subsequent research have treated DSIP as an endogenous neuropeptide of uncertain physiological function, which is part of why it remains an active subject of basic study.
Molecular identity
The following identity values reflect commonly reported laboratory attributes and are provided for comparison only. The DSIP research peptide is typically supplied as a lyophilized powder, for example the DSIP 15 mg research vial catalogued for laboratory use.
| Attribute | Reported detail |
|---|---|
| Name | Delta Sleep-Inducing Peptide (DSIP) |
| Amino acid sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Sequence length | 9 residues (nonapeptide) |
| Approximate molecular weight | 848.8 Da |
| Molecular formula | C35H48N10O15 |
| Class | Endogenous neuropeptide |
| First described | Monnier and Schoenenberger, 1970s (rabbit studies) |
How DSIP Is Studied in Sleep Research
Delta-wave activity in animal models
Most of the primary literature on DSIP uses animal models and in-vitro systems. Investigators have paired peptide administration in rodents and rabbits with EEG recordings to look for shifts toward slow-wave (delta) frequencies, the low-frequency oscillations that characterize deep non-REM sleep in mammals. Reported findings across laboratories have been variable, and some groups have not reproduced the original sleep-associated observations. This inconsistency is itself a reason the peptide is still studied: researchers continue to probe whether the early correlations reflect a direct signaling role or a downstream marker of other processes.
Proposed neuromodulatory roles
Preclinical reports have examined DSIP for possible interactions with neurotransmitter systems, stress-response pathways, and thermoregulation in animals. These are described in the literature as exploratory associations, not established functions. Because DSIP is a small, endogenous sequence, part of the research interest lies in mapping where and how it is produced and degraded, rather than in any applied outcome. Nothing in this body of work supports a human application, and the compound is examined strictly as a reference material.
Related Peptides in Sleep and Circadian Biology
Sleep-active and wake-promoting peptides
DSIP is one entry in a wider set of peptides studied in sleep neuroscience. Orexin (hypocretin) is investigated as a wake-promoting signal acting at the OX1R and OX2R receptors, and loss of orexin signaling is a well-studied model of disrupted sleep-wake stability in animals. Galanin is examined in sleep-active neurons of the ventrolateral preoptic area, while growth hormone-releasing hormone (GHRH) has been studied by Krueger and colleagues for its association with non-REM sleep in rodents.
Circadian signaling peptides
Circadian research focuses on peptides that help synchronize the SCN. Vasoactive intestinal peptide (VIP) is central to keeping SCN neurons in phase with one another, and arginine vasopressin and PACAP are studied as additional SCN signaling molecules. The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Peptide | Class / length | Approx. molecular weight | Studied target or pathway |
|---|---|---|---|
| DSIP | Nonapeptide (9 aa) | ~849 Da | Delta EEG activity, neuromodulation |
| Orexin-A | Neuropeptide (33 aa) | ~3562 Da | OX1R / OX2R, wakefulness |
| VIP | Neuropeptide (28 aa) | ~3326 Da | SCN synchronization, circadian phase |
| GHRH | Neuropeptide (44 aa) | ~5040 Da | Non-REM sleep in animal models |
| Galanin | Neuropeptide (29-30 aa) | ~3212 Da | Sleep-active preoptic neurons |
Related short peptides in the nootropic research cluster, such as Selank and Semax, are sometimes discussed alongside these compounds because they are studied for neuromodulatory activity, though they are not classical sleep or circadian peptides.
Laboratory Handling and Sourcing Considerations
Stability and storage
Like most small research peptides, DSIP is generally supplied lyophilized and is kept cold and protected from repeated freeze-thaw cycles to preserve sequence integrity. Reconstitution for laboratory work is typically performed with bacteriostatic water; as a single worked example, reconstituting a 15 mg vial with 3 mL of bacteriostatic water yields a 5 mg/mL stock. Rather than restating general technique here, consult the dedicated bacteriostatic water reconstitution guide for handling detail.
Purity and sourcing
Because the sleep and circadian literature depends on well-characterized inputs, purity verification matters. A certificate of analysis (COA) documents identity and purity by mass spectrometry and HPLC, and published third-party certificates allow independent review of a given lot. Guidance on evaluating a research peptide supplier is useful when comparing sources, and the full research peptide catalog lists related compounds. Every item referenced here is offered for research use only, not for human consumption, and should be handled only by qualified personnel in an appropriate laboratory setting.
Frequently Asked Questions
What are sleep peptides?
Sleep peptides is an informal term for endogenous peptides that laboratory researchers study in connection with sleep architecture and circadian timing. Examples include delta sleep-inducing peptide, orexin, and vasoactive intestinal peptide. The term describes a research category and does not imply any established sleep product or human effect.
What is DSIP (delta sleep-inducing peptide)?
DSIP is a naturally occurring nonapeptide, meaning it is built from nine amino acids, that was first characterized in rabbit studies in the 1970s. It was named for its observed association with delta-wave EEG activity in those animal experiments. It is studied today as a neuromodulatory research peptide.
Is DSIP a hormone or a peptide?
DSIP is a peptide, a short chain of amino acids. Some researchers have described it as showing hormone-like signaling behavior in animal models, but it is classified as an endogenous neuropeptide rather than a classical hormone.
What is the difference between sleep peptides and circadian peptides?
The categories overlap. Sleep peptides are studied mainly for their relationship to sleep states such as slow-wave sleep, while circadian peptides, such as vasoactive intestinal peptide, are studied for their role in the timing signals produced by the suprachiasmatic nucleus. Many peptides are examined in both contexts.
How is DSIP studied in the laboratory?
In preclinical settings, DSIP is examined using animal models and in-vitro systems, often with EEG recordings, receptor and neurotransmitter assays, and stability testing. These studies characterize the peptide and its interactions rather than evaluate any human application.
Are sleep and circadian peptides available for human use?
No. The compounds discussed here are supplied for research use only, not for human consumption. They are handled as laboratory reference materials and are not intended for self-administration, diagnosis, or therapeutic use.
References and Further Reading
- Monnier M, Schoenenberger GA. Early characterization of delta sleep-inducing peptide (DSIP) in rabbit studies (1970s). PubMed: delta sleep-inducing peptide
- Studies of DSIP and delta EEG activity in animal models. PubMed: DSIP delta EEG sleep
- Sakurai T, de Lecea L, and others on orexin (hypocretin) and the sleep-wake system. PubMed: orexin hypocretin sleep
- Vasoactive intestinal peptide and synchronization of the suprachiasmatic nucleus. PubMed: vasoactive intestinal peptide circadian
- Krueger and colleagues on growth hormone-releasing hormone and non-REM sleep. PubMed: growth hormone releasing hormone sleep
- Galanin and sleep-active neurons of the preoptic area. PubMed: galanin sleep preoptic
- Reviews of neuropeptide signaling in circadian rhythm regulation. PubMed: neuropeptides circadian rhythm
